Financials data is unavailable for this security.
View more
Year on year Finch Therapeutics Group Inc had revenues fall -87.57% from 861.00k to 107.00k, though the company grew net income from a loss of 114.65m to a smaller loss of 74.75m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -25.20% |
|---|---|
| Return on equity | -67.28% |
| Return on investment | -28.80% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Finch Therapeutics Group Inc fell by 46.33m. However, Cash Flow from Investing totalled 1.33m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 31.51m for operations while cash used for financing totalled 16.16m.
| Cash flow per share | -8.68 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 8.86 |
|---|---|
| Tangible book value per share | 8.86 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.87 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
